CSI Market
Sign In | Register

Rock Creek Pharmaceuticals (RCPI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access RCPI Annual Cash Flow →
The table below presents a historical view of Rock Creek Pharmaceuticals's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2016)
6 Months 		(Mar 31 2016) (Dec 31 2015) (Sep 30 2015) (Jun 30 2015)
Operating Activities
Income-5.49
Depreciation & amortization0.03
Amortization of Other Assets0.25
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)0.00
Provision For Loan Losses Expensed0.00
Inventory Write-down0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation0.07
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.72
Gain Loss On Sale Of Curing Barns-
Debt Instrument Decrease Forgiveness-
Insurance Proceeds Receivable Current-
Obligation To Pay Settlement For Securities-
Forgiveness Of Debt In Non Cash Investing And Financing Activities-
Gain Loss On Release Of Unvested Options-
Income taxes0.00
Gain (Loss) on Sale of Derivatives0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable, Trade-0.10
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital0.54
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.07
Discontinued operations-0.07
Net Cash flow from Operating Activities-3.98
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Deposits Made Returned On Property And Equipment-
Proceeds From Sale Of Licensing Rights-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Sale of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.19
Long-term debt - borrowings6.41
Long-term debt - repayments-3.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.01
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Stock And Warrant Exercise0.50
Deposits To Msa Escrow-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.74
Effect of exchange rate on cash flow0.00
Discontinued operations-0.07
Free Cash Flow-3.98
Total Cash Flow-0.31
4 historic quarters locked

Sign in to unlock the full Rock Creek Pharmaceuticals cash flow history.

Sign In Create Free Account

About RCPI Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.